Trial Profile
A Phase II Clinical Trial Study on Apatinib and XELOX Combination Regimen in the First-line Treatment of End-stage Colorectal Cancer Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 Jul 2016 New trial record